MSC pretreated with cisplatin showed increased phosphorylation of multiple tyrosine kinases such as PLC-y1, WNK1, RSK1/2/3, c-Jun, STAT3 and p53 (Fig. 2b), which could play a role in the MSC-mediated changes of tumor cells. Here, TP53 is linked to neoplasm.